Insights

  • Date

  • Content Type

  • Reset

Article

Why Regulatory Convergence is Key to Global Development of Cell and Gene Therapies

20.12.22

By Francesco Lanucara

There is growing excitement about the potential shown by cell and gene therapies, particularly in

Article

Managing the Complex Regulatory Pathways for Bioprinting Breakthroughs

20.12.22

By Elena Meurer and Mariya Gromova

Bioprinted products are already starting to demonstrate life-changing potential, but the path to commercialisation is

Article

Reimbursement of ATMPs in Germany: Challenges, opportunities and key initiatives

15.11.22

By Liron Sarid-Krebs ,Carolin Denzinger , Zaklina Buljovcic

Liron Sarid-Krebs Associate Principal Consultant and Team Lead at Biopharma Excellence. Carolin Denzinger  Director, Head

Article

Vaccine Equity for Africa: A moment of pride for the Biopharma Excellence team

8.11.22
by Michael Pfleiderer, Ph.D., principal consultant and senior director When our team from Biopharma Excellence

Article

Why Regulatory Convergence is Key to Global Development of Cell and Gene Therapies

17.10.22

By Francesco Lanucara

There is growing excitement about the potential shown by cell and gene therapies, particularly in | Read Time 5min

Article

Challenge accepted: Teams seeking a quantum shift for new antiviral agents through Germany’s federal agency SPRIN-D

20.09.22

By Dr. Maximilian Strunz

In 2021, the German Federal Agency for Disruptive Innovation, SPRIN-D, announced an antiviral challenge to